Jane Street Group LLC Buys 39,364 Shares of Core Laboratories Inc. (NYSE:CLB)

Jane Street Group LLC raised its stake in Core Laboratories Inc. (NYSE:CLB - Free Report) by 54.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 111,353 shares of the oil and gas company's stock after acquiring an additional 39,364 shares during the period. Jane Street Group LLC owned approximately 0.24% of Core Laboratories worth $1,928,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of CLB. Isthmus Partners LLC lifted its position in Core Laboratories by 5.6% in the 4th quarter. Isthmus Partners LLC now owns 11,219 shares of the oil and gas company's stock valued at $194,000 after acquiring an additional 599 shares in the last quarter. Smartleaf Asset Management LLC lifted its position in Core Laboratories by 173.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company's stock valued at $35,000 after acquiring an additional 1,293 shares in the last quarter. Assetmark Inc. bought a new position in Core Laboratories in the 4th quarter valued at approximately $26,000. Jones Financial Companies Lllp lifted its position in Core Laboratories by 10.6% in the 4th quarter. Jones Financial Companies Lllp now owns 16,383 shares of the oil and gas company's stock valued at $284,000 after acquiring an additional 1,569 shares in the last quarter. Finally, JPMorgan Chase & Co. lifted its position in Core Laboratories by 5.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 41,281 shares of the oil and gas company's stock valued at $765,000 after acquiring an additional 2,267 shares in the last quarter. 97.81% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CLB has been the topic of several analyst reports. Stifel Nicolaus lowered their price objective on Core Laboratories from $19.00 to $15.00 and set a "hold" rating on the stock in a research report on Tuesday, April 15th. Citigroup lowered their price objective on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 13th. Finally, Wall Street Zen cut Core Laboratories from a "hold" rating to a "sell" rating in a report on Friday, April 25th. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $15.00.

Core Laboratories Stock Performance

Shares of NYSE CLB traded down $0.05 during midday trading on Friday, hitting $10.88. 434,650 shares of the stock traded hands, compared to its average volume of 405,172. The firm has a 50-day moving average of $12.62 and a two-hundred day moving average of $16.20. The firm has a market capitalization of $509.85 million, a P/E ratio of 16.48, a PEG ratio of 0.99 and a beta of 1.45. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.71 and a current ratio of 2.32. Core Laboratories Inc. has a one year low of $10.14 and a one year high of $25.13.

Core Laboratories (NYSE:CLB - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). The firm had revenue of $123.59 million for the quarter, compared to the consensus estimate of $125.09 million. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. Core Laboratories's quarterly revenue was down 4.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.19 earnings per share. On average, equities analysts forecast that Core Laboratories Inc. will post 0.96 EPS for the current fiscal year.

Core Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Monday, May 5th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Monday, May 5th. This represents a $0.04 dividend on an annualized basis and a yield of 0.37%. Core Laboratories's dividend payout ratio is currently 6.78%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.